Short- and long-term impact of aspirin cessation in older adults: a target trial emulation.

Zhen ZhouKatherine L WebbMark R NelsonRobyn L WoodsMichael E ErnstAnne M MurrayAndrew T ChanAndrew TonkinChristopher M ReidSuzanne G OrchardBrenda KirpachRaj C ShahNigel StocksJonathan C BroderRory Wolfe

Published in: BMC medicine (2024)

Our findings suggest that deprescribing prophylactic aspirin might be safe in healthy older adults with no known CVD.

Keyphrases

low dose
physical activity
cardiovascular events
antiplatelet therapy
study protocol
phase iii
clinical trial
anti inflammatory drugs
middle aged
community dwelling
acute coronary syndrome
percutaneous coronary intervention
randomized controlled trial
type diabetes